Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice
2011 StandoutNobel
Development and validation of the Nancy histological index for UC
2015 Standout
Gut, inflammation and osteoporosis: basic and clinical concepts
2008
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
2012 Standout
Neutralization of IFNγ defeats haemophagocytosis in LCMV‐infected perforin‐ and Rab27a‐deficient mice
2009
Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon
2017 Standout
Cytokines in inflammatory bowel disease
2014 Standout
New insights into T cell biology and T cell‐directed therapy for autoimmunity, inflammation, and immunosuppression
2010
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
TL1A (TNFSF15) Regulates the Development of Chronic Colitis by Modulating Both T-Helper 1 and T-Helper 17 Activation
2008
Intracellular degradation of secretion defect‐type mutants of antithrombin is inhibited by proteasomal inhibitors
1997 StandoutNobel
The fundamental basis of inflammatory bowel disease
2007
Review article: infliximab therapy for inflammatory bowel disease – seven years on
2006
Ulcerative Colitis
2011 Standout
The pro- and anti-inflammatory properties of the cytokine interleukin-6
2011 Standout
Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease
2009
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Type I interferons in infectious disease
2015 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics
2010
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Deep-vein thrombosis
1999
Inflammatory Bowel Disease
2009 Standout
New therapies for inflammatory bowel disease: from the bench to the bedside
2011
Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality studyCommentary: Role of other genes and environment should not be overlooked in monogenic disease
2001
Biological Therapies for Inflammatory Bowel Diseases
2009
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Inflammation and Colon Cancer
2010 Standout
T cell–directed therapies: lessons learned and future prospects
2006
Crohn's disease: beyond antagonists of tumour necrosis factor
2008
Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine
2008 Standout
Crohn's disease
2016 Standout
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Diagnostics of Inflammatory Bowel Disease
2007
Type 1 diabetes
2013 Standout
Compartmentalized Expression of Th1 and Th17 Cytokines in Pediatric Inflammatory Bowel Diseases
2011
Ulcerative colitis
2016 Standout
Averting inflammation by targeting the cytokine environment
2010
The regulation of inflammation by interferons and their STATs
2013
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
2009 Standout
Evolving knowledge and therapy of inflammatory bowel disease
2006
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Ulcerative colitis
2020 Standout
Review article: altering the natural history of Crohn's disease – evidence for and against current therapies
2006
World distribution of factor V Leiden
1995 Standout
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
2008 Standout
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Structure and signalling in the IL-17 receptor family
2009 Standout
Targeting the development and effector functions of TH17 cells
2007
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Inflammatory bowel disease diagnosis, evaluation and classification: state-of-the art approach
2007
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Prothrombin 20210A Mutation
2004
Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study
2009
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Role of cytokines in inflammatory bowel disease
2008
Antithrombin Mutation Database: 2nd (1997) Update
1997
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases
2013
Graft Vascular Disease: Immune Response Meets the Vessel Wall
2008
Inherited Thrombophilia: Part 1
1996
Guidelines for the Primary Prevention of Stroke
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Cytokine Storm
2020 Standout
Inflammatory Bowel Disease
2010 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Epidemiology of coagulation disorders
1992
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
The Pathogenesis of Venous Thromboembolism: Evidence for Multiple Interrelated Causes
2006
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
2008
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
2010
Hereditary Deficiency of Protein C or Protein S Confers Increased Risk of Arterial Thromboembolic Events at a Young Age
2008
Venous thrombosis: a multicausal disease
1999 Standout
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives
2009
Works of DW Hommes being referenced
Interleukin-10 producing [i]Lactococcus lactis[/i] for the treatment of Crohn's disease
2005
A randomized controlled trial evaluating the ideal medical management for Crohn's disease (CD): Top-down versus step-up strategies
2005
The ideal management of Crohn's disease: Top down versus step up strategies, a randomized controlled trial
2006
Mortality in hereditary antithrombin-III deficiency—1830 to 1989
1991
Fontolizumab, a humanised anti-interferon antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease
2005
Susceptibility Genes in Pediatric‐onset IBD Compared with Healthy Controls and Adult‐onset IBD
2006
Interleukin-10 producing Lactococcus lactis for the treatment of Crohn??s disease
2005